APH
56
7
ADM
47
2
O
33
2
SIG
46
2
ADP
54
-4
STZ
42
-2
HD
28
-4
ROK
47
4
TGNA
53
-3
FITB
75
2
M
58
5
INTU
60
-3
T
23
2
NWSA
64
-15
KMB
31
-11
KO
44
-2
KIM
50
-3
BEN
55
2
FTI
69
11
MMC
53
-5
APH
56
7
ADM
47
2
O
33
2
SIG
46
2
ADP
54
-4
STZ
42
-2
HD
28
-4
ROK
47
4
TGNA
53
-3
FITB
75
2
M
58
5
INTU
60
-3
T
23
2
NWSA
64
-15
KMB
31
-11
KO
44
-2
KIM
50
-3
BEN
55
2
FTI
69
11
MMC
53
-5
Financhill
Back

Virtus LifeSci Biotech Clinical Trials ETF Stock Predictions

Share Price Moved. Momentum Hasn't Slowed.

DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radi
Buy
69

BBC
Virtus LifeSci Biotech Clinical Trials ETF

Last Price:
$40.10
Seasonality Move:
-0.67%

7 Day Trial

ALL ACCESS PASS

$ 7

14K Investors Got In Earlier. You Still Can.

DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radi

Virtus LifeSci Biotech Clinical Trials ETF Stock Forecast

  • Over the next 52 weeks, Virtus LifeSci Biotech Clinical Trials ETF has on average historically risen by 8% based on the past 10 years of stock performance.
  • Virtus LifeSci Biotech Clinical Trials ETF has risen higher in 5 of those 10 years over the subsequent 52-week period, corresponding to a historical accuracy of 50%
  • Is Virtus LifeSci Biotech Clinical Trials ETF Stock Undervalued?
    The current Virtus LifeSci Biotech Clinical Trials ETF [BBC] share price is $39.47. The Score for BBC is 69, which is 38% above its historic median score of 50, and infers lower risk than normal.
  • BBC is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.

Will Virtus LifeSci Biotech Clinical Trials ETF Stock Go Up Next Year?

  • Over the next 52 weeks, Virtus LifeSci Biotech Clinical Trials ETF has on average historically risen by 8% based on the past 10 years of stock performance.

Virtus LifeSci Biotech Clinical Trials ETF Stock Rating

Buy
69
Virtus LifeSci Biotech Clinical Trials ETF (BBC) is a Buy

Is Virtus LifeSci Biotech Clinical Trials ETF overpriced?

  • Virtus LifeSci Biotech Clinical Trials ETF has risen higher in 5 of those 10 years over the subsequent 52-week period, corresponding to a historical accuracy of 50%

Virtus LifeSci Biotech Clinical Trials ETF Stock Price History

Is BBC stock going to rise?

  • Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and BBC is experiencing slight buying pressure.

Stock Information

Stock Info

Exchange:
NYSEARCA
Country:
Industry:
Sector:
Type:
etf
Website:

52-Week Data

52-Week High:
40.82
52-Week Low:
13.42

Prediction Charts

Market Cap:
0
Price in USD:
39.47
Volume:
48.7K
Beta:
1.30

Technical Analysis

SMA50:
34.01
SMA100:
29.03
SMA200:
24.05
52-Wk Change:
62.88%

Stock Predictions

  • Is Virtus LifeSci Biotech Clinical Trials ETF stock public?
    Yes, Virtus LifeSci Biotech Clinical Trials ETF is a publicly traded company.
  • What is the Virtus LifeSci Biotech Clinical Trials ETF stock quote today?
    The Virtus LifeSci Biotech Clinical Trials ETF stock price is 39.47 USD today.
  • How to buy Virtus LifeSci Biotech Clinical Trials ETF stock online?
    You can buy Virtus LifeSci Biotech Clinical Trials ETF shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Dec-2 36.62 35.31 36.62 35.14
Dec-3 35.58 37.34 37.40 35.58
Dec-4 37.23 38.19 38.39 36.97
Dec-5 38.62 38.49 38.71 38.26
Dec-8 39.33 40.29 40.82 39.21
Dec-9 40.36 39.35 40.44 39.28
Dec-10 39.22 39.81 39.98 39.22
Dec-11 39.88 40.05 40.51 39.64
Dec-12 40.01 39.95 40.62 39.72
Dec-15 40.25 39.80 40.65 39.79
Dec-16 39.65 39.70 40.01 39.15
Dec-17 39.70 38.58 40.25 38.54
Dec-18 39.09 38.57 39.67 38.44
Dec-19 38.60 39.47 40.10 38.60

Virtus LifeSci Biotech Clinical Trials ETF Earnings

Data Unavailable

Virtus LifeSci Biotech Clinical Trials ETF Forecast Revenue Growth

Data Unavailable

* Virtus LifeSci Biotech Clinical Trials ETF stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.